Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Registry Study of the Safety of Iluvien® 190 Micrograms Intravitreal Implant in Applicator

NCT01998412 is registered in ClinicalTrials.gov with Alimera Sciences as lead sponsor.

NCT NCT01998412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01998412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Registry Study of the Safety of Iluvien® 190 Micrograms Intravitreal Implant in Applicator
Lead sponsor
Alimera Sciences
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2013
Completion date
January 31, 2020
Enrollment
559 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic diabetic macular oedema considered insufficiently responsive to available therapies